Tianjin TEDA Biomedical Engineering Company Limited announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was CNY 86.338 million compared to CNY 83.728 million a year ago. Net loss was CNY 10.645 million compared to CNY 7.323 million a year ago. Basic loss per share was CNY 0.00561 compared to CNY 0.00389 a year ago. For the nine months, sales was CNY 251.610 million compared to CNY 284.484 million a year ago. Net loss was CNY 15.911 million compared to CNY 14.158 million a year ago. Basic loss per share was CNY 0.00839 compared to CNY 0.0075 a year ago.